专题：Inflammasome and immune disorders

This cluster of papers focuses on the molecular mechanisms of inflammasome activation, regulation, and its role in inflammatory responses, cell death (pyroptosis), and immune-related diseases. It covers topics such as NLRP3 inflammasome, interleukin-1, caspase-1, and the involvement of mitochondria in inflammasome activation.
最新文献
High admission levels of interleukin-1 receptor antagonist in acute myocardial infarction patients are associated with increased rates of all-cause mortality and cardiac death at five years follow-up

article Full Text OpenAlex

Juvenile Idiopathic Arthritis

review Full Text OpenAlex

Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances

review Full Text OpenAlex

Caspase-1–dependent pyroptosis converts αSMA + CAFs into collagen-III high iCAFs to fuel chemoresistant cancer stem cells

article Full Text OpenAlex

NINJ1 regulates plasma membrane fragility under mechanical strain

article Full Text OpenAlex

Succinate drives gut inflammation by promoting FOXP3 degradation through a molecular switch

article Full Text OpenAlex

Colchicine for Cardiovascular Disease

article Full Text OpenAlex

Breaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments

article Full Text OpenAlex

cGAS-STING targeting offers a novel therapeutic paradigm in cardiovascular diseases

review Full Text OpenAlex

Genome-wide association study of long COVID

article Full Text OpenAlex

近5年高被引文献
Pyroptosis: mechanisms and diseases

review Full Text OpenAlex 1745 FWCI40.198

Necroptosis, pyroptosis and apoptosis: an intricate game of cell death

review Full Text OpenAlex 1585 FWCI34.958

The cGAS–STING pathway as a therapeutic target in inflammatory diseases

review Full Text OpenAlex 1573 FWCI34.935

The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics

review Full Text OpenAlex 1182 FWCI41.686

NLRP3 inflammasome activation and cell death

review Full Text OpenAlex 1054 FWCI23.627

Multiple early factors anticipate post-acute COVID-19 sequelae

article Full Text OpenAlex 954 FWCI150.156

Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19

article Full Text OpenAlex 880 FWCI103.262

NLRP3 inflammasome in cancer and metabolic diseases

review Full Text OpenAlex 846 FWCI19.645

Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19

review Full Text OpenAlex 836 FWCI24.13

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

article Full Text OpenAlex 802 FWCI124.84